Fumarate hydratase variant prevalence and manifestations among individuals receiving germline testing is a dataset published in Cancer (2021). On theSindex it has a DataRank of 0.973, placing it in the top 20.8% of the data-sharing corpus. It has been cited 31 times, with 25 citing works in its 1-hop citation network.
Ranks in the top 21% for downstream scientific impact
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.520
From this paper's citation signal
Citation Network Contribution
0.453
From 17 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 25 citers.
National Institutes of Health
Grant: U24CA248265
National Institutes of Health
Grant: R01CA244729
Prostate Cancer Foundation
Grant: 20CHAS01
NCI NIH HHS
Grant: P30 CA016042
National Cancer Institute Early Detection Research Network
Grant: 1U01CA214194-01
NCI NIH HHS
Grant: U01 CA214194
MeSH Terms
Keywords